{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["PPAR\u03b3", "macrophage", "ozone", "pulmonary lipids"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "37202362", "DateCompleted": {"Year": "2023", "Month": "06", "Day": "30"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "19"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["10.1093/toxsci/kfad048"], "Journal": {"ISSN": "1096-0929", "JournalIssue": {"Volume": "194", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "28"}}, "Title": "Toxicological sciences : an official journal of the Society of Toxicology", "ISOAbbreviation": "Toxicol Sci"}, "ArticleTitle": "Role of PPAR\u03b3 in dyslipidemia and altered pulmonary functioning in mice following ozone exposure.", "Pagination": {"StartPage": "109", "EndPage": "119", "MedlinePgn": "109-119"}, "Abstract": {"AbstractText": ["Exposure to ozone causes decrements in pulmonary function, a response associated with alterations in lung lipids. Pulmonary lipid homeostasis is dependent on the activity of peroxisome proliferator activated receptor gamma (PPAR\u03b3), a nuclear receptor that regulates lipid uptake and catabolism by alveolar macrophages (AMs). Herein, we assessed the role of PPAR\u03b3 in ozone-induced dyslipidemia and aberrant lung function in mice. Exposure of mice to ozone (0.8\u2009ppm, 3\u2009h) resulted in a significant reduction in lung hysteresivity at 72\u2009h post exposure; this correlated with increases in levels of total phospholipids, specifically cholesteryl esters, ceramides, phosphatidylcholines, phosphorylethanolamines, sphingomyelins, and di- and triacylglycerols in lung lining fluid. This was accompanied by a reduction in relative surfactant protein-B (SP-B) content, consistent with surfactant dysfunction. Administration of the PPAR\u03b3 agonist, rosiglitazone (5\u2009mg/kg/day, i.p.) reduced total lung lipids, increased relative amounts of SP-B, and normalized pulmonary function in ozone-exposed mice. This was associated with increases in lung macrophage expression of CD36, a scavenger receptor important in lipid uptake and a transcriptional target of PPAR\u03b3. These findings highlight the role of alveolar lipids as regulators of surfactant activity and pulmonary function following ozone exposure and suggest that targeting lipid uptake by lung macrophages may be an efficacious approach for treating altered respiratory mechanics."], "CopyrightInformation": "\u00a9 The Author(s) 2023. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com."}, "AuthorList": [{"Identifier": ["0000-0003-2388-4032"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of Connecticut School of Pharmacy, Storrs, Connecticut 06269, USA."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Smith", "ForeName": "Ley Cody", "Initials": "LC"}, {"Identifier": ["0000-0003-0876-5158"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Gow", "ForeName": "Andrew J", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Abramova", "ForeName": "Elena", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Vayas", "ForeName": "Kinal", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Guo", "ForeName": "Changjiang", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Noto", "ForeName": "Jack", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Lyman", "ForeName": "Jack", "Initials": "J"}, {"Identifier": ["0000-0001-9124-4243"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Rodriquez", "ForeName": "Jessica", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Gelfand-Titiyevskiy", "ForeName": "Benjamin", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Malcolm", "ForeName": "Callum", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental and Occupational Health and Justice, School of Public Health, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Laskin", "ForeName": "Jeffrey D", "Initials": "JD"}, {"Identifier": ["0000-0003-1832-7311"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, USA."}], "LastName": "Laskin", "ForeName": "Debra L", "Initials": "DL"}], "DataBankList": [{"DataBankName": "Dryad", "AccessionNumberList": ["10.5061/dryad.4f4qrfjh1"]}], "GrantList": [{"GrantID": "T32 ES007148", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "P30 ES005022", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R00 ES032473", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "F32 ES030984", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "K99 ES032473", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES004738", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R25 ES020721", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "S10 OD026876", "Acronym": "OD", "Agency": "NIH HHS", "Country": "United States"}, {"GrantID": "T32 GM139804", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Toxicol Sci", "NlmUniqueID": "9805461", "ISSNLinking": "1096-0929"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "PPAR gamma"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "0", "NameOfSubstance": "Phospholipids"}, {"RegistryNumber": "0", "NameOfSubstance": "Surface-Active Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "PPAR gamma"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lung"}, {"QualifierName": ["metabolism"], "DescriptorName": "Macrophages, Alveolar"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phospholipids"}, {"QualifierName": [], "DescriptorName": "Surface-Active Agents"}, {"QualifierName": ["chemically induced", "metabolism"], "DescriptorName": "Dyslipidemias"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Agassandian M., Mallampalli R. K. (2013). Surfactant phospholipid metabolism. Biochim. Biophys. Acta 1831, 612\u2013625.", "ArticleIdList": ["PMC3562414", "23026158"]}, {"Citation": "Agudelo C. W., Samaha G., Garcia-Arcos I. (2020). Alveolar lipids in pulmonary disease. A review. Lipids Health Dis. 19, 122.", "ArticleIdList": ["PMC7268969", "32493486"]}, {"Citation": "Ahmed R. A. M., Murao K., Imachi H., Yu X., Li J., Wong N. C. W., Ishida T. (2009). Human scavenger receptor class B type 1 is regulated by activators of peroxisome proliferators-activated receptor-gamma in hepatocytes. Endocrine 35, 233\u2013242.", "ArticleIdList": ["19156545"]}, {"Citation": "Aronoff D. M., Serezani C. H., Carstens J. K., Marshall T., Gangireddy S. R., Peters-Golden M., Reddy R. C. (2007). Stimulatory effects of peroxisome proliferator-activated receptor-gamma on Fcgamma receptor-mediated phagocytosis by alveolar macrophages. PPAR Res. 2007, 52546.", "ArticleIdList": ["PMC2220046", "18253476"]}, {"Citation": "Baker A. D., Malur A., Barna B. P., Ghosh S., Kavuru M. S., Malur A. G., Thomassen M. J. (2010). Targeted PPAR\u03b3 deficiency in alveolar macrophages disrupts surfactant catabolism. J. Lipid Res. 51, 1325\u20131331.", "ArticleIdList": ["PMC3035495", "20064973"]}, {"Citation": "Batenburg J. J. (1992). Surfactant phospholipids: Synthesis and storage. Am. J. Physiol. 262, L367\u2013L385.", "ArticleIdList": ["1566854"]}, {"Citation": "Beers M. F., Wali A., Eckenhoff M. F., Feinstein S. I., Fisher J. H., Fisher A. B. (1992). An antibody with specificity for surfactant protein C precursors: Identification of pro-SP-C in rat lung. Am. J. Respir. Cell Mol. Biol. 7, 368\u2013378.", "ArticleIdList": ["1389209"]}, {"Citation": "Bligh E. G., Dyer W. J. (1959). A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917.", "ArticleIdList": ["13671378"]}, {"Citation": "Bouhlel M. A., Derudas B., Rigamonti E., Dievart R., Brozek J., Haulon S., Zawadzki C., Jude B., Torpier G., Marx N., et al. (2007). PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137\u2013143.", "ArticleIdList": ["17681149"]}, {"Citation": "Brandsma J., Goss V. M., Yang X., Bakke P. S., Caruso M., Chanez P., Dahl\u00e9n S.-E., Fowler S. J., Horvath I., Krug N., et al.; U-BIOPRED Study Group. (2018). Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers. Metabolomics 14, 123.", "ArticleIdList": ["PMC6153688", "30830396"]}, {"Citation": "Cabello N., Mishra V., Sinha T., DiAngelo S. L., Chroneos Z. C., Ekpa N. A., Cooper T. K., Caruso C. R., Silveyra P. (2015). Sex differences in the expression of lung inflammatory mediators in response to ozone. Am. J. Physiol. Lung Cell. Mol. Physiol. 309, L1150\u2013L1163.", "ArticleIdList": ["PMC4652152", "26342085"]}, {"Citation": "Castillo-S\u00e1nchez J. C., Cerrada A., Conde M., Cruz A., Perez-Gil J. (2022). Compositional, structural and functional properties of discrete coexisting complexes within bronchoalveolar pulmonary surfactant. Biochim. Biophys. Acta Biomembr. 1864, 183808.", "ArticleIdList": ["34687755"]}, {"Citation": "Chawla A., Boisvert W. A., Lee C. H., Laffitte B. A., Barak Y., Joseph S. B., Liao D., Nagy L., Edwards P. A., Curtiss L. K., et al. (2001). A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 7, 161\u2013171.", "ArticleIdList": ["11172721"]}, {"Citation": "Chen L., Vasoya R. P., Toke N. H., Parthasarathy A., Luo S., Chiles E., Flores J., Gao N., Bonder E. M., Su X., et al. (2020). HNF4 regulates fatty acid oxidation and is required for renewal of intestinal stem cells in mice. Gastroenterology 158, 985\u2013999.e9.", "ArticleIdList": ["PMC7062567", "31759926"]}, {"Citation": "Chinetti G., Lestavel S., Bocher V., Remaley A. T., Neve B., Torra I. P., Teissier E., Minnich A., Jaye M., Duverger N., et al. (2001). PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat. Med. 7, 53\u201358.", "ArticleIdList": ["11135616"]}, {"Citation": "Cochrane C. G., Revak S. D. (1991). Pulmonary surfactant protein B (SP-B): Structure\u2013function relationships. Science 254, 566\u2013568.", "ArticleIdList": ["1948032"]}, {"Citation": "Crouch E., Hartshorn K., Ofek I. (2000). Collectins and pulmonary innate immunity. Immunol. Rev. 173, 52\u201365.", "ArticleIdList": ["10719667"]}, {"Citation": "Currie W. D., van Schaik S., Vargas I., Enhorning G. (1998a). Breathing and pulmonary surfactant function in mice 24 h after ozone exposure. Eur. Respir. J. 12, 288\u2013293.", "ArticleIdList": ["9727776"]}, {"Citation": "Currie W. D., van Schaik S. M., Vargas I., Enhorning G. (1998b). Ozone affects breathing and pulmonary surfactant function in mice. Toxicology 125, 21\u201330.", "ArticleIdList": ["9585097"]}, {"Citation": "Dodd C. E., Pyle C. J., Glowinski R., Rajaram M. V. S., Schlesinger L. S. (2016). CD36-mediated uptake of surfactant lipids by human macrophages promotes intracellular growth of Mycobacterium tuberculosis. J. Immunol. 197, 4727\u20134735.", "ArticleIdList": ["PMC5137803", "27913648"]}, {"Citation": "Eidelman D. H., Ghezzo H., Kim W. D., Hyatt R. E., Cosio M. G. (1989). Pressure\u2013volume curves in smokers. Comparison with alpha-1-antitrypsin deficiency. Am. Rev. Respir. Dis. 139, 1452\u20131458.", "ArticleIdList": ["2786362"]}, {"Citation": "Fakhrzadeh L., Laskin J. D., Laskin D. L. (2002). Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury. Am. J. Respir. Cell Mol. Biol. 26, 413\u2013419.", "ArticleIdList": ["11919077"]}, {"Citation": "Fakhrzadeh L., Laskin J. D., Laskin D. L. (2004). Ozone-induced production of nitric oxide and TNF-alpha and tissue injury are dependent on NF-kappaB p50. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L279\u2013L285.", "ArticleIdList": ["15064226"]}, {"Citation": "Fakhrzadeh L., Laskin J. D., Laskin D. L. (2008). Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-alpha following ozone inhalation. Toxicol. Appl. Pharmacol. 227, 380\u2013389.", "ArticleIdList": ["PMC3507418", "18207479"]}, {"Citation": "Francis M., Guo G., Kong B., Abramova E. V., Cervelli J. A., Gow A. J., Laskin J. D., Laskin D. L. (2020). Regulation of lung macrophage activation and oxidative stress following ozone exposure by farnesoid X receptor. Toxicol. Sci. 177, 441\u2013453.", "ArticleIdList": ["PMC7548292", "32984886"]}, {"Citation": "Glasser S. W., Burhans M. S., Korfhagen T. R., Na C. L., Sly P. D., Ross G. F., Ikegami M., Whitsett J. A. (2001). Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc. Natl. Acad. Sci. U.S.A 98, 6366\u20136371.", "ArticleIdList": ["PMC33474", "11344267"]}, {"Citation": "Gorki A.-D., Symmank D., Zahalka S., Lakovits K., Hladik A., Langer B., Maurer B., Sexl V., Kain R., Knapp S. (2022). Murine ex vivo cultured alveolar macrophages provide a novel tool to study tissue-resident macrophage behavior and function. Am. J. Respir. Cell Mol. Biol. 66, 64\u201375.", "ArticleIdList": ["PMC8803354", "34586974"]}, {"Citation": "Groves A. M., Gow A. J., Massa C. B., Laskin J. D., Laskin D. L. (2012). Prolonged injury and altered lung function after ozone inhalation in mice with chronic lung inflammation. Am. J. Respir. Cell Mol. Biol. 47, 776\u2013783.", "ArticleIdList": ["PMC3547091", "22878412"]}, {"Citation": "Gurel O., , IkegamiM., , ChroneosZ. C., and , Jobe A. H. (2001). Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L1266\u2013L1272.", "ArticleIdList": ["11350807"]}, {"Citation": "Holm B. A., Wang Z., Egan E. A., Notter R. H. (1996). Content of dipalmitoyl phosphatidylcholine in lung surfactant: Ramifications for surface activity. Pediatr. Res. 39, 805\u2013811.", "ArticleIdList": ["8726232"]}, {"Citation": "Holm S. M., Balmes J. R. (2022). Systematic review of ozone effects on human lung function, 2013 through 2020. Chest 161, 190\u2013201.", "ArticleIdList": ["PMC8783034", "34389296"]}, {"Citation": "Huang S. C.-C., Everts B., Ivanova Y., O\u2019Sullivan D., Nascimento M., Smith A. M., Beatty W., Love-Gregory L., Lam W. Y., O\u2019Neill C. M., et al. (2014). Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 15, 846\u2013855.", "ArticleIdList": ["PMC4139419", "25086775"]}, {"Citation": "Hussell T., and , Bell T. J. (2014). Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14, 81\u201393.", "ArticleIdList": ["24445666"]}, {"Citation": "Ikegami M., Jobe A. H. (1998). Surfactant protein metabolism in vivo. Biochim. Biophys. Acta 1408, 218\u2013225.", "ArticleIdList": ["9813337"]}, {"Citation": "Liu S., Zhang H., Li Y., Zhang Y., Bian Y., Zeng Y., Yao X., Wan J., Chen X., Li J., et al. (2021). S100A4 enhances protumor macrophage polarization by control of PPAR-\u03b3-dependent induction of fatty acid oxidation. J. Immunother. Cancer 9, e002548.", "ArticleIdList": ["PMC8215236", "34145030"]}, {"Citation": "Lopez-Rodriguez E., P\u00e9rez-Gil J. (2014). Structure\u2013function relationships in pulmonary surfactant membranes: From biophysics to therapy. Biochim. Biophys. Acta 1838, 1568\u20131585.", "ArticleIdList": ["24525076"]}, {"Citation": "Lugg S. T., Scott A., Parekh D., Naidu B., Thickett D. R. (2022). Cigarette smoke exposure and alveolar macrophages: Mechanisms for lung disease. Thorax 77, 94\u2013101.", "ArticleIdList": ["PMC8685655", "33986144"]}, {"Citation": "Massa C. B., Scott P., Abramova E., Gardner C., Laskin D. L., Gow A. J. (2014). Acute chlorine gas exposure produces transient inflammation and a progressive alteration in surfactant composition with accompanying mechanical dysfunction. Toxicol. Appl. Pharmacol. 278, 53\u201364.", "ArticleIdList": ["PMC4361901", "24582687"]}, {"Citation": "Massa C. B., Groves A. M., Jaggernauth S. U., Laskin D. L., Gow A. J. (2017). Histologic and biochemical alterations predict pulmonary mechanical dysfunction in aging mice with chronic lung inflammation. PLoS Comput. Biol. 13, e1005570.", "ArticleIdList": ["PMC5570219", "28837561"]}, {"Citation": "Matyash V., Liebisch G., Kurzchalia T. V., Shevchenko A., Schwudke D. (2008). Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 1137\u20131146.", "ArticleIdList": ["PMC2311442", "18281723"]}, {"Citation": "Milad N., Morissette M. C. (2021). Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure. Eur. Respir. Rev. 30, 210077.", "ArticleIdList": ["PMC9489000", "34911693"]}, {"Citation": "Mirakaj V., Mutz C., Vagts D., Henes J., Haeberle H. A., Husung S., K\u00f6nig T., N\u00f6ldge-Schomburg G., Rosenberger P. (2014). Rosiglitazone dampens pulmonary inflammation in a porcine model of acute lung injury. Inflammation 37, 1102\u20131110.", "ArticleIdList": ["24497162"]}, {"Citation": "Nachtman J. P., Hajratwala B. R., Moon H. L., Gross K. B., Wright E. S. (1986). Surface-tension measurements of pulmonary lavage from ozone-exposed rats. J. Toxicol. Environ. Health 19, 127\u2013136.", "ArticleIdList": ["3746939"]}, {"Citation": "Nambiar S., Clynick B., How B. S., King A., Walters E. H., Goh N. S., Corte T. J., Trengove R., Tan D., Moodley Y. (2021). There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF). Respir. Res. 22, 105.", "ArticleIdList": ["PMC8033725", "33836757"]}, {"Citation": "Olmeda B., , Mart\u00ednez-CalleM., and , P\u00e9rez-Gil J. (2017). Pulmonary surfactant metabolism in the alveolar airspace: Biogenesis, extracellular conversions, recycling. Ann. Anat. 209, 78\u201392.", "ArticleIdList": ["27773772"]}, {"Citation": "Prokhorova S., Patel N., Laskin D. L. (1998). Regulation of alveolar macrophage and type II cell DNA synthesis: Effects of ozone inhalation. Am. J. Physiol. 275, L1200\u2013L1207.", "ArticleIdList": ["9843858"]}, {"Citation": "Punjabi C. J., Laskin J. D., Pendino K. J., Goller N. L., Durham S. K., Laskin D. L. (1994). Production of nitric oxide by rat type II pneumocytes: Increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am. J. Respir. Cell Mol. Biol. 11, 165\u2013172.", "ArticleIdList": ["7519435"]}, {"Citation": "Putman E., Liese W., Voorhout W. F., van Bree L., van Golde L. M., Haagsman H. P. (1997). Short-term ozone exposure affects the surface activity of pulmonary surfactant. Toxicol. Appl. Pharmacol. 142, 288\u2013296.", "ArticleIdList": ["9070351"]}, {"Citation": "Ross M., Krol S., Janshoff A., Galla H.-J. (2002). Kinetics of phospholipid insertion into monolayers containing the lung surfactant proteins SP-B or SP-C. Eur. Biophys. J. 31, 52\u201361.", "ArticleIdList": ["12046897"]}, {"Citation": "R\u00f6szer T., Men\u00e9ndez-Guti\u00e9rrez M., Lefterova M. I., Alameda D., N\u00fa\u00f1ez V., Lazar M. A., Fischer T., Ricote M. (2011). Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J. Immunol. 186, 621\u2013631.", "ArticleIdList": ["PMC4038038", "21135166"]}, {"Citation": "R\u00f6szer T. (2017). Transcriptional control of apoptotic cell clearance by macrophage nuclear receptors. Apoptosis 22, 284\u2013294.", "ArticleIdList": ["27787652"]}, {"Citation": "Schachtrup C., Malcharek S., Haitsma J. J., Lachmann B., Owada Y., Binas B., Kondo H., R\u00fcstow B., Galla H.-J., Spener F. (2008). Activation of PPARgamma reverses a defect of surfactant synthesis in mice lacking two types of fatty acid binding protein. Biochim. Biophys. Acta 1781, 314\u2013320.", "ArticleIdList": ["18485924"]}, {"Citation": "Sch\u00fcrch D., Ospina O. L., Cruz A., P\u00e9rez-Gil J. (2010). Combined and independent action of proteins SP-B and SP-C in the surface behavior and mechanical stability of pulmonary surfactant films. Biophys. J. 99, 3290\u20133299.", "ArticleIdList": ["PMC2980747", "21081077"]}, {"Citation": "Sehlmeyer K., Ruwisch J., Roldan N., Lopez-Rodriguez E. (2020). Alveolar dynamics and beyond\u2014the importance of surfactant protein C and cholesterol in lung homeostasis and fibrosis. Front. Physiol. 11, 386.", "ArticleIdList": ["PMC7213507", "32431623"]}, {"Citation": "Serrano A. G., P\u00e9rez-Gil J. (2006). Protein\u2013lipid interactions and surface activity in the pulmonary surfactant system. Chem. Phys. Lipids 141, 105\u2013118.", "ArticleIdList": ["16600200"]}, {"Citation": "Sunil V. R., Patel-Vayas K., Shen J., Laskin J. D., Laskin D. L. (2012). Classical and alternative macrophage activation in the lung following ozone-induced oxidative stress. Toxicol. Appl. Pharmacol. 263, 195\u2013202.", "ArticleIdList": ["PMC3670689", "22727909"]}, {"Citation": "Sunil V. R., Vayas K. N., Cervelli J. A., Ebramova E. V., Gow A. J., Goedken M., Malaviya R., Laskin J. D., Laskin D. L. (2018). Protective role of surfactant protein-D against lung injury and oxidative stress induced by nitrogen mustard. Toxicol. Sci. 166, 108\u2013122.", "ArticleIdList": ["PMC6204765", "30060251"]}, {"Citation": "Sunil V. R., Francis M., Vayas K. N., Cervelli J. A., Choi H., Laskin J. D., Laskin D. L. (2015). Regulation of ozone-induced lung inflammation and injury by the \u03b2-galactoside-binding lectin galectin-3. Toxicol. Appl. Pharmacol. 284, 236\u2013245.", "ArticleIdList": ["PMC4408237", "25724551"]}, {"Citation": "Tontonoz P., Nagy L., Alvarez J. G., Thomazy V. A., Evans R. M. (1998). PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241\u2013252.", "ArticleIdList": ["9568716"]}, {"Citation": "Trapnell B. C., Whitsett J. A., Nakata K. (2003). Pulmonary alveolar proteinosis. N. Engl. J. Med. 349, 2527\u20132539.", "ArticleIdList": ["14695413"]}, {"Citation": "Walther F. J., Hern\u00e1ndez-Juviel J. M., Gordon L. M., Waring A. J., Stenger P., Zasadzinski J. A. (2005). Comparison of three lipid formulations for synthetic surfactant with a surfactant protein B analog. Exp. Lung Res. 31, 563\u2013579.", "ArticleIdList": ["16019988"]}, {"Citation": "Wang Z., Hall S. B., Notter R. H. (1996). Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant. J. Lipid Res. 37, 790\u2013798.", "ArticleIdList": ["8732779"]}, {"Citation": "Wright J. R., and , Dobbs L. G. (1991). Regulation of pulmonary surfactant secretion and clearance. Annu. Rev. Physiol. 53, 395\u2013414.", "ArticleIdList": ["2042966"]}, {"Citation": "Zhang B., Berger J., Hu E., Szalkowski D., White-Carrington S., Spiegelman B. M., Moller D. E. (1996). Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol. Endocrinol. 10, 1457\u20131466.", "ArticleIdList": ["8923470"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "30", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "19", "Hour": "1", "Minute": "4"}, {"Year": "2023", "Month": "5", "Day": "18", "Hour": "22", "Minute": "13"}, {"Year": "2024", "Month": "5", "Day": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37202362", "PMC10306402", "10.1093/toxsci/kfad048", "7172391"]}}], "PubmedBookArticle": []}